The primary endpoint for the trial as defined by a SPA is progression free survival. OS will be less relevant as patients in the treatment arm are allowed to move on to Adcetris at progression. This is how first-line Hodgkin's lymphoma trials readout.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.